EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Fatty acid Sources: 6

Krill oil

Also called: Antarctic krill oil, Euphausia superba oil

An oil extracted from Antarctic krill (Euphausia superba), small shrimp-like marine crustaceans. It supplies the long-chain omega-3 fatty acids EPA and DHA, mainly in the form of phospholipids. General omega-3 information is in the omega-3 fatty acids entry.

Category
Fatty acid
Forms
Krill oil (omega-3s mainly as phospholipids); lysophosphatidylcholine-rich oil extracts of Antarctic krill also appear on FDA's NDI list
Strongest evidence
B Some positive trials
Reviewed
2026-10-30

Class 1 Well studied in people. A 2023 systematic review and meta-analysis of randomized controlled trials included 14 trials (18 treatment arms, 1,458 participants) of krill oil supplementation and cardiovascular risk factors. [2]

Fact-checked 2026-10-30 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

3 topics studied3 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Krill oil does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Krill oil, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Blood lipidsBA 2017 meta-analysis (7 RCTs, 662 participants) found lower LDL cholesterol (-15.52 mg/dL) and triglycerides (-14.03 mg/dL) and higher HDL (+6.65 mg/dL); the change in total cholesterol was not significant. [3]
Blood pressure, glycemic control, body composition and inflammatory markersXA 2023 meta-analysis (14 trials, 1,458 participants) found lower total cholesterol, LDL and triglycerides but no effect on blood pressure, glycemic control, body composition or inflammatory markers. [2]
Knee pain, stiffness and functionCA 2024 meta-analysis (5 RCTs, 700 patients) found no significant difference from placebo for knee pain, stiffness or lipids, and a small improvement in knee physical function (SMD -0.24). [4]

Main constituents: Long-chain omega-3s (EPA and DHA), present primarily as phospholipids [1]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • The 2017 meta-analysis included trials of at least 2 weeks of krill oil supplementation. [3]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Score E
    A: well known causeE: unlikely cause

    NIH LiverTox, Omega-3 Fatty Acids (last update April 8, 2017; the chapter names krill oil among marine sources): likelihood score E, unlikely cause …

    Details and sources
  • Pregnancy and breastfeeding
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Interactions with medicines
    1 listed

    Anticoagulants and antiplatelet agents

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    4 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • LiverTox (omega-3 fatty acids chapter, which names krill oil among marine oil sources): side effects of omega-3 supplements at typical doses are minimal (mild gastrointestinal discomfort, nausea, diarrhea, headache); platelet dysfunction and an increased risk of bleeding are more clinically significant. [5]
Interactions

Interactions

Known interactions of Krill oil
WithWhat happens
Anticoagulants and antiplatelet agentsLiverTox (omega-3 fatty acids): severe events with prescription omega-3 products may include an increased risk of bleeding, particularly with other anticoagulants or antiplatelet agents. [5]

Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.

Quality

Identity, quality and standardization

  • ODS: some studies suggest the phospholipid omega-3s in krill oil have somewhat higher bioavailability than the omega-3s in fish oil, whereas other studies do not. [1]
Regulation

Regulatory status

  • US: ODS lists krill oil among the dietary supplement formulations that contain long-chain omega-3s. [1]
  • US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [6]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-30). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Omega-3s in the form of phospholipids Fatty acids and lipids (omega-3 phospholipids) [P6]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 4 entries naming krill oil or an oil extract of Antarctic krill (Euphausia superba) (earliest NDI 155 submitted 2002-03-13; most recent NDI 1360 submitted 2024-09-12); 4 more entries name other krill products (a protein concentrate, freeze-dried krill, krill powder and a krill enzyme product). Each notification covers one firm's specific ingredient and conditions of use; the list does not state FDA's response. [P1]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of krill oil was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-30). [P2]
  • The NTP Technical Reports index (TR-001 to TR-606) lists no 2-year study of krill oil (checked 2026-10-30). [P3]

Liver (NIH LiverTox)

  • NIH LiverTox, Omega-3 Fatty Acids (last update April 8, 2017; the chapter names krill oil among marine sources): likelihood score E, unlikely cause of clinically apparent liver injury. [P7]

Interactions with medicines

  • Anticoagulants and antiplatelet agents: LiverTox (omega-3 fatty acids): severe events with prescription omega-3 products may include an increased risk of bleeding, particularly with other anticoagulants or antiplatelet agents. [P7]

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P4]

Supply and conservation

  • IUCN Red List: Least Concern (LC) for Euphausia superba, via GBIF species API, retrieved 2026-10-30. [P8]

Absorption in people

  • ODS: krill oil contains omega-3s primarily as phospholipids; some studies suggest somewhat higher bioavailability than the omega-3s in fish oil, whereas other studies do not. [P5]

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • No published information found in the sources checked.

Sources for this profile

  1. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  2. IARC Monographs. List of Classifications (last update 2026-07-23; checked 2026-10-30), 2026-07-23. monographs.iarc.who.int
  3. National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606; checked 2026-10-30), 2026-10-30. ntp.niehs.nih.gov
  4. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (current text, retrieved 2026-10-30), 2026-10-30. ecfr.gov
  5. NIH Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals (no printed update date; page last modified 2026-10-24 per page metadata), 2026-10-24. ods.od.nih.gov
  6. NCCIH. Omega-3 Supplements: What You Need To Know (Last Updated: November 2024), 2024-11. nccih.nih.gov
  7. NIH LiverTox. Omega-3 Fatty Acids (Last Update: April 8, 2017), 2017-04-08. ncbi.nlm.nih.gov
  8. GBIF species API: IUCN Red List category for Euphausia superba Dana, 1850 (usageKey 2228010), 2026-10-30. api.gbif.org
Sources

Sources

  1. NIH Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals (no printed update date; page last modified 2026-10-24 per page metadata), 2026-10-24. ods.od.nih.gov
  2. Huang H, et al. Clinical effectiveness of krill oil supplementation on cardiovascular health in humans: an updated systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr 2023;17(12):102909 (PMID 38039646), 2023-12. pubmed.ncbi.nlm.nih.gov
  3. Ursoniu S, et al. Lipid-modifying effects of krill oil in humans: systematic review and meta-analysis of randomized controlled trials. Nutr Rev 2017;75(5):361-373 (PMID 28371906), 2017-05-01. pubmed.ncbi.nlm.nih.gov
  4. Pimentel T, et al. Krill oil supplementation for knee pain: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials. Inflammopharmacology 2024;32(5):3109-3118 (PMID 39126570), 2024-10. pubmed.ncbi.nlm.nih.gov
  5. NIH LiverTox. Omega-3 Fatty Acids (Last Update: April 8, 2017), 2017-04-08. ncbi.nlm.nih.gov
  6. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in fatty acid: Algal oil (DHA and EPA) · Arachidonic acid · Argan oil · Conjugated linoleic acid (CLA) · Evening primrose oil · GLA oils (borage and blackcurrant seed oil) · Linoleic acid · MCT oil (medium-chain triglycerides) · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.